Patents by Inventor David Scopes

David Scopes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRROLO [3,2-E] [1,2,4] TRIAZOLO [1,5-A] PYRIMIDINES DERIVATIVES AS INHIBITORS OF MICROGLIA ACTIVATION
    Publication number: 20120289523
    Abstract: The invention relates to novel compounds useful in the treatment and prophylaxis of disease. Compounds of the formula (I) wherein X is halogen, independently selected form chlorine and fluorine and n is 0, 1 or 2, and their pharmaceutically acceptable salts are useful in the treatment and prophylaxis of diseases caused by activation of microglia, particularly Alzheimer's disease.
    Type: Application
    Filed: October 7, 2010
    Publication date: November 15, 2012
    Applicants: BTG INTERNATIONAL LIMITED, SENEXIS LIMITED
    Inventor: David Scopes
  • PYRROLO [3,2-E] [1,2,4] TRIAZOLO [1,5-A] PYRIMIDINES DERIVATIVES AS INHIBITORS OF MICROGLIA ACTIVATION
    Publication number: 20120289524
    Abstract: The invention relates to novel compounds useful in the treatment and prophylaxis of disease. Compounds of the formula (I): wherein X is halogen, independently selected form chlorine and fluorine and their pharmaceutically acceptable salts are useful in the treatment and prophylaxis of diseases caused by activation of microglia, particularly Alzheimer's disease.
    Type: Application
    Filed: October 7, 2010
    Publication date: November 15, 2012
    Applicant: Senexis Limited
    Inventors: David Scopes, David Horwell
  • 2-Hydroxymethyl-3,4,5-Trihydroxy-1-(4-Pentyloxybenzyl) Piperidine as Glucosylceramide Synthase (Gcs) Inhibitor
    Publication number: 20070259918
    Abstract: The compound 3,4,5-piperidinetriol, 2-(hydroxymethyl)-1-[(4-(pentyloxy)phenyl)methyl]-, (2S,3S,4R,5S), or a pharmaceutically acceptable salt or prodrug thereof, is useful as an inhibitor of glucosylceramide synthase.
    Type: Application
    Filed: June 9, 2004
    Publication date: November 8, 2007
    Applicant: Actelion Pharmaceuticals, Ltd.
    Inventors: Michael Orchard, David Scopes
  • Furanthiazole derivatives as heparanase inhibitors
    Publication number: 20060128768
    Abstract: The invention provides a compound of formula (I) or a pharmaceutically acceptable salt or prodrug thereof. (I) wherein the groups Q, R2, R3, R4 and R5 represent various substituent groups, and their use as inhibitors of heparanase.
    Type: Application
    Filed: August 5, 2003
    Publication date: June 15, 2006
    Inventors: Stephen Courtney, Philip Hay, David Scopes
  • Phthalimide carboxylic acid derivatives
    Publication number: 20050203153
    Abstract: The present invention relates to phthalimide carboxylic acid derivatives of formula (I), methods for their preparation, pharmaceutical compositions containing them and their use in medicine, specifically in the treatment of cancer. (I), wherein X is O or S; R1 is a phthalimide carboxylic acid group of formula (II). R is hydrogen, C1-C6 alkyl, aryl or C1-C3 alkylaryl and R2, R3 and R4 represent various substituents.
    Type: Application
    Filed: March 6, 2003
    Publication date: September 15, 2005
    Inventors: Stephen Courtney, Philip Hay, David Scopes